KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Gains from Investment Securities: 2013-2025

Historic Gains from Investment Securities for CareDx (CDNA) over the last 10 years, with Sep 2025 value amounting to $1.1 million.

  • CareDx's Gains from Investment Securities fell 49.23% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year increase of 78.51%. This contributed to the annual value of $10.1 million for FY2024, which is 229.91% up from last year.
  • Per CareDx's latest filing, its Gains from Investment Securities stood at $1.1 million for Q3 2025, which was down 81.62% from $6.2 million recorded in Q2 2025.
  • CareDx's Gains from Investment Securities' 5-year high stood at $18.0 million during Q4 2021, with a 5-year trough of -$147,000 in Q2 2021.
  • Its 3-year average for Gains from Investment Securities is $2.1 million, with a median of $1.3 million in 2023.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first tumbled by 293.42% in 2021, then soared by 2,801.61% in 2024.
  • CareDx's Gains from Investment Securities (Quarterly) stood at $18.0 million in 2021, then plummeted by 71.65% to $5.1 million in 2022, then plummeted by 73.98% to $1.3 million in 2023, then spiked by 168.60% to $3.6 million in 2024, then plummeted by 49.23% to $1.1 million in 2025.
  • Its Gains from Investment Securities was $1.1 million in Q3 2025, compared to $6.2 million in Q2 2025 and $3.1 million in Q1 2025.